Skip to main content

Table 6 Evolution of mean scores over time in quality of life and mood of patients with advanced cancer at baseline, 12, 18 and 24 weeks

From: Is early integration of palliative home care in oncology treatment feasible and acceptable for advanced cancer patients and their health care providers? A phase 2 mixed-methods study

Patients’ outcomes

Range

Assessment

Baseline (t0)

12 weeks (t1)

18 weeks (t2)

24 weeks (t3)

P value

(N = 30)

(N = 26)

(N = 22)

(N = 18)

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

EORTC QLQ C-30

 Global QOL

0–100

60,5 ± 16

58 ± 17,7

61,9 ± 17,6

62,5 ± 17,2

0,81

 Physical functioning

0–100

60,9 ± 23,8

60,5 ± 23,2

60,9 ± 21,2

65,4 ± 23,1

0,90

 Role functioning

0–100

59,4 ± 31,5

51,3 ± 29,6

53 ± 28

55,6 ± 32,8

0,78

 Emotional functioning

0–100

69,6 ± 18,3

66 ± 24,6

67 ± 23,4

70,8 ± 24

0,88

 Cognitive functioning

0–100

75 ± 23,1

68 ± 25,4

75 ± 25,1

69,4 ± 29,8

0,67

 Social functioning

0–100

72,2 ± 23

73,1 ± 20,6

75,8 ± 19,1

69,4 ± 29,8

0,86

HADS

 HADS – anxiety

0–21

7,9 ± 4,1

7 ± 4

6,2 ± 4,3

7,5 ± 5,1

0,55

 HADS – depression

0–21

7,4 ± 3,6

7,3 ± 4,3

6,6 ± 3,7

7,1 ± 4,5

0,90

  1. EORTC QLQ C-30: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (for all the EORTC QLQ C-30 scales the higher the score, the better quality of life); HADS Hospital Anxiety and Depression Scale (for both HADS subscales the higher the score, the higher the distress)